Eurocash SA
F:E07
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eurocash SA
F:E07
|
PL |
|
J
|
JSP Industrial Pharmacy (Thailand) PCL
SET:JSP
|
TH |
|
Alamo Group Inc
NYSE:ALG
|
US |
|
Elliptic Laboratories ASA
OSE:ELABS
|
NO |
|
F
|
Firefly Aerospace Inc
NASDAQ:FLY
|
US |
|
Millennium Pharmacon International Tbk PT
IDX:SDPC
|
ID |
|
M
|
MFC Asset Management PCL
SET:MFC
|
TH |
|
Dev Clever Holdings PLC
LSE:DEV
|
UK |
|
Blueprint Medicines Corp
NASDAQ:BPMC
|
US |
Wall Street
Price Targets
E07 Price Targets Summary
Eurocash SA
According to Wall Street analysts, the average 1-year price target for E07 is 2.862 EUR with a low forecast of 1.185 EUR and a high forecast of 4.839 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is E07's stock price target?
Price Target
2.862
EUR
According to Wall Street analysts, the average 1-year price target for E07 is 2.862 EUR with a low forecast of 1.185 EUR and a high forecast of 4.839 EUR.
What is Eurocash SA's Revenue forecast?
Projected CAGR
2%
For the last 13 years the compound annual growth rate for Eurocash SA's revenue is 65%. The projected CAGR for the next 4 years is 2%.
What is Eurocash SA's Operating Income forecast?
Projected CAGR
11%
For the last 13 years the compound annual growth rate for Eurocash SA's operating income is 26%. The projected CAGR for the next 4 years is 11%.
